Artwork

Content provided by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Best of 2023 - Number 2

31:52
 
Share
 

Manage episode 391905469 series 3502474
Content provided by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We are continuing the Best of 2023 series on FLATLINING Podcast from Fulcrum Strategies. Weight loss drugs got a lot of hype this year as more were approved by the FDA with very promising results. But, as has been noted by several lawmakers and activists, insurance companies are still refusing to cover the drugs. Ron and Matthew discussed the new drug from Novo Nordisk called Wegovy and how it could change America’s public health. Next week: the most popular episode of 2023.
  continue reading

112 episodes

Artwork
iconShare
 
Manage episode 391905469 series 3502474
Content provided by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We are continuing the Best of 2023 series on FLATLINING Podcast from Fulcrum Strategies. Weight loss drugs got a lot of hype this year as more were approved by the FDA with very promising results. But, as has been noted by several lawmakers and activists, insurance companies are still refusing to cover the drugs. Ron and Matthew discussed the new drug from Novo Nordisk called Wegovy and how it could change America’s public health. Next week: the most popular episode of 2023.
  continue reading

112 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide